An increase in the levels of NAD+ enhanced the malignant phenotype in the cells and led to poorer outcomes, accompanied by NAMPT overexpression, which is mainly produced by the NAD+ salvage pathway in cancer cells and involved in several pro-cancer pathways mediated by NAMPT [23,24,25]. This evidence concerns the gene NAMPT and cancer.